Follow The Filings

SNWV SANUWAVE Health

SANUWAVE Health earnings company data as of 4:00 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 6 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by SNWV's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SNWV insider trades
  • None no insider bought on the open market
  • $7.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Opaleye Management Inc. 10% owner
    Sale
    $574K 35,581 shares at $16.14 88% of stake
    Traded Apr 30–May 1 Filed May 4
  2. Opaleye Management Inc. 10% owner
    Sale
    $1.3M 70,648 shares at $18.05 92% of stake
    Traded Apr 28–29 Filed Apr 30
  3. Opaleye Management Inc. 10% owner
    Sale
    $337K 16,469 shares at $20.46 1.7% of stake
    Traded Apr 17–21 Filed Apr 21
  4. Morgan C. Frank 10% owner, +4 joint filers
    Sale
    $559K 20,000 shares at $27.95 24% of stake
    Traded Dec 11–12 Filed Dec 15, 2025
  5. Morgan C. Frank 10% owner, +4 joint filers
    Sale
    $4.5M 144,810 shares at $30.73
    Traded Dec 8–10 Filed Dec 11, 2025
  6. Opaleye Management Inc. 10% owner
    Buy
    $38K 1,267 shares at $30.28 +0.1% to stake
    Traded Oct 6, 2025 Filed Oct 9, 2025

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 3.01
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01
8-K 7.01,9.01
8-K 5.07
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
DEF 14A
DEFA14A
8-K 2.02,9.01
SCHEDULE 13G/A —
10-K
8-K 2.02,9.01
8-K 4.02
8-K/A 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.